Podcast Episodes

Back to Search
Episode: 79 - Conversation with Bahija Jallal on the Biggest Anticipated Transformations and Breakthroughs
Episode: 79 - Conversation with Bahija Jallal on the Biggest Anticipated Transformations and Breakthroughs

Season 2 Episode 79

November 11, 2025 | What is the next modality to focus on in the next 10 years? For Bahija Jallal, CEO of Immunocore, it would be T-cell engagers. In…

10 months ago

Short Long
View Episode
Episode: 78 - Shamit Shrivastava on an Interdisciplinary Approach to Antibody Biophysics and Developability
Episode: 78 - Shamit Shrivastava on an Interdisciplinary Approach to Antibody Biophysics and Developability

Season 2 Episode 78

As drug development pushes into more complex antibody formats, the big question is: how do you really assess developability? In this episode, host Ni…

11 months ago

Short Long
View Episode
Episode: 77 - Derek Lowe on AI and the US Biotech Ecosystem
Episode: 77 - Derek Lowe on AI and the US Biotech Ecosystem

Season 2 Episode 77

September 16, 2025 | With the rise of AI and automation, what is the core human skill in drug discovery that is and will be valuable in the future? D…

11 months, 4 weeks ago

Short Long
View Episode
Alexey Lugovskoy Shares Decades of Experience in Starting Out and Founding Companies
Alexey Lugovskoy Shares Decades of Experience in Starting Out and Founding Companies

Season 2 Episode 76

August 12, 2025 | Diagonal Therapeutics founder and CEO Alexey Lugovskoy discusses the key lessons learned over his illustrious career, starting from…

1 year, 1 month ago

Short Long
View Episode
Episode: 75 - Are Licensing Fees Required or Gatekeeping?
Episode: 75 - Are Licensing Fees Required or Gatekeeping?

Season 2 Episode 75

July 15, 2025 | Are licensing fees required or gatekeeping? In this episode of The Chain, host Nimish Gera, vice president of Biologics at Mythic The…

1 year, 1 month ago

Short Long
View Episode
Episode: 74 - Keith Flaherty, President-Elect of AACR, on Public and Private Collabs, AI Optimism, and More
Episode: 74 - Keith Flaherty, President-Elect of AACR, on Public and Private Collabs, AI Optimism, and More

Season 2 Episode 74

June 10, 2025 | In this bonus episode of The Chain, Daniel Chen, MD, PhD, founder and CEO of Synthetic Design Lab, returns for the Science Commune se…

1 year, 3 months ago

Short Long
View Episode
Episode: 73 - PANEL DISCUSSION: Near-Term Challenges for AI/ML in Biotherapeutic R&D
Episode: 73 - PANEL DISCUSSION: Near-Term Challenges for AI/ML in Biotherapeutic R&D

Season 2 Episode 73

June 10, 2025 | This episode of The Chain features a panel discussion from May’s PEGS Boston. Moderated by Peter Tessier, Albert M. Mattocks professo…

1 year, 3 months ago

Short Long
View Episode
Episode: 72 - Pamela Barney on HR Lessons to Meet the Needs of Biotech
Episode: 72 - Pamela Barney on HR Lessons to Meet the Needs of Biotech

Season 2 Episode 72

In this episode of The Chain, host Tariq Ghayur, PhD, Tariq Ghayur Consulting, LLC, talks with Pamela Barney, former associate director of HR, AbbVie…

1 year, 4 months ago

Short Long
View Episode
PEGS Young Scientist Keynote Jessica Stark on the Role of Glycans in Cancer Research
PEGS Young Scientist Keynote Jessica Stark on the Role of Glycans in Cancer Research

Season 2 Episode 71

In this episode of The Chain, host Brandon DeKosky, associate professor, speaks with MIT colleague Jessica Stark, Underwood-Prescott career developme…

1 year, 5 months ago

Short Long
View Episode
Episode: 70 -  Views on Machine Learning and AI in the Antibody and Protein Engineering Space
Episode: 70 - Views on Machine Learning and AI in the Antibody and Protein Engineering Space

Season 2 Episode 70

March 11, 2025 | In this episode of The Chain, host Andrew Buchanan, principal scientist at AstraZeneca, and Andreas Plückthun, professor and head of…

1 year, 6 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us